2019
DOI: 10.1111/petr.13574
|View full text |Cite
|
Sign up to set email alerts
|

Lymphocyte subset at time of Epstein‐Barr viremia post‐allogeneic hematopoietic stem cell transplantation in children may predict development of post‐transplant lymphoproliferative disease: CD8:CD20 ratio as a sensitive predictor

Abstract: EBV–associated PTLD following allogeneic HSCT is a serious complication associated with significant mortality. In this retrospective study, we evaluated whether lymphocyte subset numbers and CD8:CD20 ratio at time of EBV viremia in children undergoing allogeneic HSCT could predict development of PTLD. Absolute lymphocyte count, lymphocyte subsets, and CD8:CD20 ratio at the time of EBV viremia were analyzed. Patients who were treated preemptively with rituximab for high blood EBV viral load were excluded. Out o… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
2

Citation Types

1
5
0

Year Published

2020
2020
2024
2024

Publication Types

Select...
4

Relationship

0
4

Authors

Journals

citations
Cited by 4 publications
(6 citation statements)
references
References 21 publications
1
5
0
Order By: Relevance
“…Of note, PTLD subtypes are inconsistently reported and mostly not within the frame of the most recent WHO classification. Across studies, there is again a wide variability in the reported incidence, ranging from as low as 0% to 3.5% in children [4,[8][9][10][11] and 0% to 14% in adults [12][13][14][15][16][17][18][19][20][21][22][23][24][25][26][27][28][29][30][31], falling within the range of previously reported incidences. Again, this variability most likely results from the heterogeneity of the transplant populations studied, GvHD prophylaxis, including the use of ATG or not, conditioning regimen administered, as well as donor EBV status.…”
Section: Incidence Of Ebv-related Ptld After Allogeneic Hsctsupporting
confidence: 63%
See 1 more Smart Citation
“…Of note, PTLD subtypes are inconsistently reported and mostly not within the frame of the most recent WHO classification. Across studies, there is again a wide variability in the reported incidence, ranging from as low as 0% to 3.5% in children [4,[8][9][10][11] and 0% to 14% in adults [12][13][14][15][16][17][18][19][20][21][22][23][24][25][26][27][28][29][30][31], falling within the range of previously reported incidences. Again, this variability most likely results from the heterogeneity of the transplant populations studied, GvHD prophylaxis, including the use of ATG or not, conditioning regimen administered, as well as donor EBV status.…”
Section: Incidence Of Ebv-related Ptld After Allogeneic Hsctsupporting
confidence: 63%
“…The results of EBV reactivation after HSCT in both adults and children are shown in Table 1. Incidence remains highly variable, ranging from 30% to 68% in children [4,[8][9][10][11] and 19% to 86% in adults [12][13][14][15][16][17][18][19][20][21][22][23][24][25][26][27][28][29][30][31] (excluding Marinho-Diaz et al, 2018, with an unrepresentative six adults studied). This variability reflects a high level of heterogeneity in the reported patient populations, including conditioning regimens, GvHD prophylaxis, donor type, or sensitivity of diagnostic tests.…”
Section: Incidence Of Ebv-dnaemia After Allogeneic Hsctmentioning
confidence: 99%
“…In total, 3362 titles were identified in the research bases, 1883 in EMBASE and 1479 in Medline. Once duplicates and papers with exclusion criteria were removed, 77 articles [ 4 , 16 , 23 , 24 , 27 , 31 , 32 , 33 , 34 , 35 , 36 , 37 , 38 , 39 , 40 , 41 , 42 , 43 , 44 , 45 , 46 , 47 , 48 , 49 , 50 , 51 , 52 , 53 , 54 , 55 , 56 , 57 , 58 , 59 , 60 , 61 , 62 , 63 , 64 , 65 , 66 , 67 , 68 , 69 , 70 , 71 , 72 , 73 , 74 , 75 , 76 , 77 , 78 , 79 , 80 ,…”
Section: Resultsmentioning
confidence: 99%
“…The method used to diagnose PTLD was not detailed in one study. The length of follow-up was an important source of variation between studies; in some cases the follow-up period was not reported [ 31 , 32 , 34 , 40 , 46 , 48 , 52 , 55 , 59 , 61 , 63 , 73 , 81 , 83 , 86 , 90 , 94 , 98 , 100 ].…”
Section: Resultsmentioning
confidence: 99%
See 1 more Smart Citation